EDAP TMS Earnings Per Share Growth
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
None selected
Date range:
to
<Embed Chart>
Pro Save as Image
Pro Data Export
Copy the code below and paste
into the embed destination.
into the embed destination.
Attention
OK
EDAP Earnings Per Share Growth Range, Past 5 Years
| Minimum | -53.33% | Dec 2001 |
| Maximum | 500.00% | Mar 2002 |
| Average | 223.33% |
About EPS Growth
YCharts EPS growth rates are calculated as quarterly year on year growth rates.
EPS growth (earnings per share growth) illustrates the growth of earnings per share over time. EPS growth rates help investors identify stocks that are increasing or decreasing in profitability.
If a company has an EPS of $5.00 in 2008 and EPS of $6.00 in 2009, the company has an EPS growth rate of $6.00/$5.00 - 1 = 20% during fiscal year 2009.
Learn More
You may also be interested in these EDAP related companies
EDAP News
EDAP Regains Ablatherm(R)-HIFU Distribution Rights in Canada and Caribbean
Jan 30, 8:30AM GlobeNewswire
Jan 30, 8:30AM GlobeNewswire
keep $edap on your watch list...$btx is nice too (obama stem cell play)
about 18 days ago by MarketMaker
about 18 days ago by MarketMaker
$EDAP http://stks.co/24GQ Battle at the 200 day, broke out of descending channel
about 19 days ago by Tr8r_x
about 19 days ago by Tr8r_x
$EDAP is presenting this week at the ArabHealth Exhibition and perhaps good news is on the way.
about 19 days ago by jarnolaine
about 19 days ago by jarnolaine
@RyanNinz If volume stays high, then $EDAP can still run. There are lot of old holders looking to get out.
about 19 days ago by jarnolaine
about 19 days ago by jarnolaine
Great technology both lithotripsy and HIFU technology,micro-floater, big runner late 2011,ready 2 go $EDAP http://chart.ly/2oagy3w
about 35 days ago by Wiserguy1971
about 35 days ago by Wiserguy1971
$EDAP http://stks.co/1orC Kumo breakout, 10 headed for 50,macd curled, fib targets on chart
about 36 days ago by Tr8r_x
about 36 days ago by Tr8r_x
$EDAP is flying with some volume, but no news. What's up? Will it fade?
about 38 days ago by jarnolaine
about 38 days ago by jarnolaine
$EDAP is in tight range and BB is pinching. There is going to be a big move one way or the other. Maybe earnings next week is the catalyst.
about 95 days ago by jarnolaine
about 95 days ago by jarnolaine
EDAP Schedules Webcast and Conference Call of Third Quarter 2011 Results
Oct 19, 8:30AM GlobeNewswire
Oct 19, 8:30AM GlobeNewswire
EDAP to Present at Rodman & Renshaw Annual Global Investment Conference
Sep 06, 8:30AM GlobeNewswire
Sep 06, 8:30AM GlobeNewswire
$EDAP http://chart.ly/63ep746 RSI recovering with higher lows, 2.72 next target then 3.03. 2.21 good entry if it touches again
about 187 days ago by Tr8r_x
about 187 days ago by Tr8r_x
$EDAP http://chart.ly/hfyx5x2 Almost a year to get approval on Sonolith I-move from lazy FDA and got it during worst week since 09
about 191 days ago by Wiserguy1971
about 191 days ago by Wiserguy1971
$EDAP http://chart.ly/dlednjx Big drop right after FDA approval on modest volume. All indicators very oversold, below lower BB.
about 192 days ago by Wiserguy1971
about 192 days ago by Wiserguy1971
$EDAP http://chart.ly/vaypett Hit trendline and rebounded. If that fails, it could get ugly.
about 192 days ago by Wiserguy1971
about 192 days ago by Wiserguy1971
$EDAP http://chart.ly/nhwqkt5 Leader in lithotripsy and HIFU technology.11 months since filing 501K with FDA for Sonolith I-move.
about 206 days ago by Wiserguy1971
about 206 days ago by Wiserguy1971
$EDAP http://chart.ly/guehfn7 catalyst at some point, waiting for approval
about 268 days ago by stockfella
about 268 days ago by stockfella
Recent Quotes
| Symbol | Price | Chg | Chg % | Market Cap |
|---|---|---|---|---|
| EDAP | 2.11 | -0.04 | -1.86% | 27.68M |
| GSAT | 0.74 | 0.05 | 7.23% | 216.88M |
| ELNK | 7.94 | -0.09 | -1.12% | 855.77M |
| JRCC | 6.38 | -0.51 | -7.40% | 227.13M |
| JNPR | 22.72 | -0.46 | -1.98% | 12.11B |
| CYTK | 1.18 | -0.01 | -0.84% | 85.29M |
| BCSI | 25.80 | 0.03 | 0.12% | 1.09B |
| IGLD | 9.67 | -0.08 | -0.82% | 185.28M |
| FMCN | 23.47 | -0.76 | -3.14% | 3.40B |
| LLNW | 3.98 | -0.12 | -2.81% | 453.32M |
